Results 61 to 70 of about 385 (131)

Aficamten in Obstructive Hypertrophic Cardiomyopathy

JACC
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, Bela Merkely, Michael E. Nassif, Maria Luisa Peña-Peña, Roberto Barriales-Villa, Ozlem Bilen, Melissa Burroughs, Brian L. Claggett, Juan Pablo Costabel, Edileide de Barros Correia, Anne Dybro, Perry Elliott, Sheila M. Hegde, Ian J. Kulac, Neal K. Lakdawala, Gregory D. Lewis, Amy Mann, Ajith Nair, Steen H. Poulsen, Patricia Reant, P. Christian Schulze, Scott D. Solomon, Regina Sohn, Indrias Berhane, Stephen B. Heitner, Daniel L. Jacoby, Stuart Kupfer, Fady I. Malik, Amy Wohltman, Michael A. Fifer, Martin S. Maron   +32 more
openaire   +1 more source

Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers. [PDF]

Heart Fail Rev
Grupper A, Sverdlov AL, Cheema BS, Nasrollahizadeh A, Hosseini K.   +4 more
europepmc   +1 more source

Efficacy and Safety of Mavacamten and Aficamten in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

Crit Pathw Cardiol
Ibrahim M, Kashif A, Arfin SMW, Mubeen M, Zafar A, Balach R, Ahmed A, Musani MH, Greene SJ, Fonarow GC, Sohail MU.   +10 more
europepmc   +1 more source

Therapeutic Sequencing in Obstructive Hypertrophic Cardiomyopathy: Seeing the Forest Through the Trees. [PDF]

JACC Heart Fail
Reza N.
europepmc   +1 more source

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

J Pers Med
Katic J, Bulum T, Borovac JA.
europepmc   +1 more source

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: Clinical Advances and Therapeutic Prospects. [PDF]

Drug Des Devel Ther
Hou L, Lin B, Ji X, Huang A.
europepmc   +1 more source

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

JAMA Cardiol
Lewis GD, Garcia-Pavia P, Masri A, Merkely B, Nassif ME, Peña-Peña ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, de Barros Correia E, Dybro AM, Kulac IJ, Lakdawala NK, Mann A, Maron MS, McGinnis S, Nair A, Newlands C, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, Elliott PM, MAPLE-HCM Investigators.   +34 more
europepmc   +1 more source

Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy

JACC: Heart Failure
Pablo Garcia-Pavia, Ozlem Bilen, Melissa Burroughs, Juan Pablo Costabel, Edileide de Barros Correia, Anne M. Dybro, Perry Elliott, Neal K. Lakdawala, Amy Mann, Ajith Nair, Michael E. Nassif, Steen H. Poulsen, Patricia Reant, P. Christian Schulze, Andrew Wang, Indrias Berhane, Stephen B. Heitner, Daniel L. Jacoby, Stuart Kupfer, Fady I. Malik, Lisa Meng, Regina Sohn, Amy Wohltman, Michael A. Fifer   +23 more
openaire   +1 more source

Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future. [PDF]

JRSM Cardiovasc Dis
Halațiu VB, Cozac DA, Scridon A.
europepmc   +1 more source

RoMa Classification: When the Parts Do Not Equal the Sum. [PDF]

J Am Heart Assoc
MacNamara JP, Angadi SS.
europepmc   +1 more source